Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
4.225
+0.105 (2.55%)
Dec 4, 2025, 4:00 PM EST - Market closed
Tvardi Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
$51.67
Upside
+1,122.96%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 14, 2025 |
| BTIG | BTIG | Strong Buy Maintains $55 → $15 | Strong Buy | Maintains | $55 → $15 | +255.03% | Oct 13, 2025 |
| Barclays | Barclays | Buy Initiates $61 | Buy | Initiates | $61 | +1,343.79% | Oct 13, 2025 |
| Raymond James | Raymond James | Buy Initiates $62 | Buy | Initiates | $62 | +1,367.46% | Jul 14, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $52 | Buy | Initiates | $52 | +1,130.77% | Jul 11, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $78 | Buy | Initiates | $78 | +1,746.15% | Jun 12, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $65 | Buy | Initiates | $65 | +1,438.46% | May 21, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $39 | Strong Buy | Initiates | $39 | +823.08% | Apr 28, 2025 |